A study of 247 first-episode psychosis patients found that earlier cigarette smoking initiation predicted earlier, faster-escalating, and heavier marijuana use before psychosis onset, while poor childhood academic performance, poor sociability, and traumatic experiences also independently contributed.
Early intervention psychosis teams; prevention researchers targeting cannabis-psychosis pathways; school-based mental health professionals.
Cigarette smoking initiation age was the strongest predictor of all premorbid marijuana use patterns
What the researchers found
Researchers examined what predicted premorbid marijuana use patterns in 247 patients with first-episode psychosis.
Three marijuana use variables were studied: age at initiation, escalation trajectory in the five years before psychosis onset, and cumulative dose.
Age at initiation of cigarette smoking was the strongest predictor, linked to all three marijuana variables: earlier marijuana initiation, faster escalation to daily use, and higher cumulative dose.
During childhood, poorer academic performance predicted earlier marijuana initiation, while poorer sociability was related to faster escalation and higher cumulative dose.
Experiencing euphoric effects from marijuana was positively correlated with escalation and cumulative dose, but having negative experiences was unrelated.
Traumatic childhood/adolescent experiences correlated with rapid escalation and amount used, but not with age of initiation.
Why it matters
Understanding what drives heavy premorbid marijuana use in people who later develop psychosis can identify early warning signs and prevention targets. The finding that cigarette smoking initiation was the strongest predictor suggests tobacco prevention could have downstream effects on cannabis-related psychosis risk.
The numbers in context
247 first-episode psychosis patients. Cigarette smoking initiation age predicted all three marijuana variables. Poor academics predicted earlier initiation. Poor sociability predicted faster escalation. Trauma predicted faster escalation and higher dose. Euphoric effects predicted escalation and dose; negative effects did not.
How the study worked
Cross-sectional analysis of 247 first-episode psychosis patients. Data on lifetime substance use, premorbid adjustment, trauma, perceived neighborhood social disorder, and cannabis use experiences. Bivariate and regression analyses.
What this study cannot tell us
Cross-sectional design with retrospective recall of premorbid use in patients already experiencing psychosis. Recall may be affected by current illness. Only first-episode patients studied; patterns may differ for cannabis users who do not develop psychosis.
How to read the evidence
Moderate. Adequate sample with multiple validated measures, but cross-sectional design with retrospective recall limits causal inference.
When this study was published
Published in 2018. Research on premorbid risk factors for cannabis-related psychosis continues to inform early intervention strategies.
The bigger picture
The pattern of converging risk factors (early smoking, poor academics, poor sociability, trauma) paints a picture of cumulative disadvantage driving heavy premorbid cannabis use. Prevention targeting any of these factors could potentially reduce the trajectory toward heavy use and subsequent psychosis.
Questions still open
- Would tobacco prevention reduce marijuana-related psychosis incidence? Can school-based monitoring of academic and social difficulties identify at-risk youth early enough for prevention? Do traumatized youth self-medicate with cannabis?
Common questions
Why does cigarette smoking predict marijuana use?
Why did negative marijuana experiences not predict reduced use?
Read the original research
Demographic and socioenvironmental predictors of premorbid marijuana use among patients with first-episode psychosis.
Schizophrenia research, 197, 544-549
Citation
Pauselli, Luca; Birnbaum, Michael L; Vázquez Jaime, Beatriz Paulina; Paolini, Enrico; Kelley, Mary E; Broussard, Beth; Compton, Michael T. (2018). Demographic and socioenvironmental predictors of premorbid marijuana use among patients with first-episode psychosis.. Schizophrenia research, 197, 544-549. https://doi.org/10.1016/j.schres.2018.01.020
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)